245 related articles for article (PubMed ID: 1681993)
1. Contribution of noradrenergic neurons to 3,4-dihydroxyphenylacetic acid concentrations in the regions of the rat brain containing incertohypothalamic dopaminergic neurons.
Tian Y; Lookingland KJ; Moore KE
Brain Res; 1991 Jul; 555(1):135-40. PubMed ID: 1681993
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical evidence that 5-hydroxytryptaminergic neurons tonically inhibit noradrenergic neurons terminating in the hypothalamus.
Tian Y; Eaton MJ; Goudreau JL; Lookingland KJ; Moore KE
Brain Res; 1993 Apr; 607(1-2):215-21. PubMed ID: 8481797
[TBL] [Abstract][Full Text] [Related]
3. Characterization of opioid receptor-mediated regulation of incertohypothalamic dopamine neurons: lack of evidence for a role of 5-hydroxytryptaminergic neurons in mediating the stimulatory effects of morphine.
Tian Y; Eaton MJ; Manzanares J; Lookingland KJ; Moore KE
Brain Res; 1992 Sep; 591(1):116-21. PubMed ID: 1332799
[TBL] [Abstract][Full Text] [Related]
4. 3-Methoxy-4-hydroxyphenylethyleneglycol concentrations in discrete hypothalamic nuclei reflect the activity of noradrenergic neurons.
Lookingland KJ; Ireland LM; Gunnet JW; Manzanares J; Tian Y; Moore KE
Brain Res; 1991 Sep; 559(1):82-8. PubMed ID: 1685939
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical identification of A13 dopaminergic neuronal projections from the medial zona incerta to the horizontal limb of the diagonal band of Broca and the central nucleus of the amygdala.
Eaton MJ; Wagner CK; Moore KE; Lookingland KJ
Brain Res; 1994 Oct; 659(1-2):201-7. PubMed ID: 7820662
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of histamine on the activity of hypothalamic dopaminergic neurons in the rat.
Fleckenstein AE; Lookingland KJ; Moore KE
J Pharmacol Exp Ther; 1994 Jan; 268(1):270-6. PubMed ID: 8301567
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of morphine on neurochemical estimates of activity of incertohypothalamic dopaminergic neurons in the male rat.
Lookingland KJ; Moore KE
Brain Res; 1985 Dec; 348(2):205-12. PubMed ID: 4075082
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor-mediated regulation of incertohypothalamic dopaminergic neurons in the male rat.
Lookingland KJ; Moore KE
Brain Res; 1984 Jun; 304(2):329-38. PubMed ID: 6331589
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Dihydroxyphenylacetic acid concentrations in the intermediate lobe and neural lobe of the posterior pituitary gland as an index of tuberohypophysial dopaminergic neuronal activity.
Lindley SE; Gunnet JW; Lookingland KJ; Moore KE
Brain Res; 1990 Jan; 506(1):133-8. PubMed ID: 2302550
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
Dunn AJ; Berridge CW
Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934
[TBL] [Abstract][Full Text] [Related]
11. Remoxipride and raclopride differentially alter the activity of incertohypothalamic dopaminergic neurons.
Eaton MJ; Tian Y; Lookingland KJ; Moore KE
Neuropharmacology; 1992 Nov; 31(11):1121-6. PubMed ID: 1475021
[TBL] [Abstract][Full Text] [Related]
12. Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
J Neurochem; 2004 Feb; 88(4):1003-9. PubMed ID: 14756822
[TBL] [Abstract][Full Text] [Related]
13. Distribution of 3,4-dihydroxyphenylacetic acid (DOPAC) and 3,4-dihydroxyphenylglycol (DOPEG) in microdissected brain structures and the pituitary gland: metabolite changes in the median eminence in response to hyperprolactinemia and suckling.
Mechanick JI; Cohen-Becker IR; Gregerson KA; Selmanoff M
J Neural Transm; 1987; 68(3-4):197-215. PubMed ID: 3559538
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus.
Guiard BP; El Mansari M; Blier P
Mol Pharmacol; 2008 Nov; 74(5):1463-75. PubMed ID: 18703671
[TBL] [Abstract][Full Text] [Related]
15. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
Pifl C; Pichler L; Kobinger W; Hornykiewicz O
Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928
[TBL] [Abstract][Full Text] [Related]
16. Effect of ventral noradrenergic bundle lesions on concentrations of monoamine neurotransmitters and metabolites in several discrete areas of the rat brain.
Johnston CA; Mattiace LA; Negro-Vilar A
Cell Mol Neurobiol; 1987 Dec; 7(4):403-11. PubMed ID: 2454160
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical characterization of the actions of 5-amino-2,4- dihydroxy-alpha-methylphenylethylamine (5-ADMP): a selective neurotoxin to central noradrenergic neurons.
Jarry H; Lookingland KJ; Palmer JR; Moore KE
J Pharmacol Exp Ther; 1986 Oct; 239(1):55-62. PubMed ID: 2428974
[TBL] [Abstract][Full Text] [Related]
18. Effects of urapidil on catecholamine turnover and release in the central nervous system of the rat.
Singer EA; Cichini G; Valenta B; Kraupp O
J Pharm Pharmacol; 1989 Mar; 41(3):173-8. PubMed ID: 2568444
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic alterations associated with enhancement of evoked release and synthesis of norepinephrine in hippocampus of chronically cold-stressed rats.
Nisenbaum LK; Abercrombie ED
Brain Res; 1993 Apr; 608(2):280-7. PubMed ID: 8098649
[TBL] [Abstract][Full Text] [Related]
20. Activation of noradrenergic neurons projecting to the diencephalon following central administration of histamine is mediated by H1 receptors.
Fleckenstein AE; Lookingland KJ; Moore KE
Brain Res; 1994 Feb; 638(1-2):243-7. PubMed ID: 7911061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
